Uncertainty In Healthcare - Market Research, Industry Trends, Market Share


Published: 03/27/2018
Pages: 98
Full Study Price: US$ 2,995

Brexit, Trump Administration healthcare policies, austerity in Europe, heavy M&A activity and the targeting of healthcare by Amazon and Apple are among the factors adding up to an "Era of Uncertainty" in healthcare, according to analysis from Kalorama Information. Current global socio-economic trends are quickly changing the way that virtually all industries operate.


This report details current challenges and upending factors in healthcare markets globally. It also processes these developments into useful market forecasts in overall healthcare and pharmaceuticals specifically, in 18 ten-year forecast tables.


Our Simple Buying Process

Choose License and Add
This Report To Your Cart.

Register, Checkout
and Verify Payment.

Receive Notification When
Your Report Is Available.

Table Of Contents

  • Executive Summary
    • The Global Healthcare Industry
    • Scope and Methodology
  • Overview
    • Introduction
    • Factor One: Global Demographic Shifts
      • Global Population Growth and Aging
        • Table Total Global Population by Region, 2008 - 2028, in Millions
        • Table Global Population of People Age 60 and Older by Region, 2008 - 2028, in Millions
      • Obesity
    • Factor Two: The Gig Economy
      • Table Key Characteristics of Employment vs. Gig Workers, 2018
      • Table Risks and Rewards of Employment vs. Gig Work, 2018
    • Factor Three: Pace of Technology Advancements Increase
    • Global Healthcare Trends
    • Factor Three: Rising Rates of Disease Diagnosis and Treatment
    • Factor Four: Growing U.S. Out of Pocket Spending on Healthcare
    • Factor Five: Alternative Therapies and Energy Medicine
    • Factor Six: Healthcare IPO Boom
      • Table Total and Healthcare Global IPO Deal Volume, 2012 - 2017
      • Table Total and Healthcare Global IPO Deal Value, 2012 - 2017, In $Billions
    • Factor Seven: Mergers and Acquisitions
      • Table Total U.S. Healthcare M&A Deal Value, 2009 - 2017, in $Billions
      • Table Selected Recent Healthcare M&A Activity
      • Product Launches
    • Factor Eight: Bitcoin and Blockchain
    • Factor Nine: Amazon and the New Healthcare Behemoths
    • Factor Ten: Threats of War
  • Key Issues: U.S.
    • Introduction
    • Factor Eleven: Affordable Care Act Changes/Individual Mandate Repeal
      • Individual Mandate Repeal
    • Factor Twelve: Association Healthcare Plans
      • Total Repeal
      • Further Changes to the ACA
    • Factor Thirteen: MACRA, PAMA and Reimbursement Changes
      • MACRA and Value Based Reimbursement
    • Factor Fourteen - Remote Patient Monitoring and Telehealth
    • Factor Fifteen: Hospital Production of Generic Medicines
    • Factor Sixteen: Legalization of Marijuana
      • Table Current and Recently-Approved State Laws Legalizing Marijuana for Medical or Recreational Purposes, Q1 2018
      • Table Federal Penalties for Marijuana Possession, Sale, Cultivation & Paraphernalia, 2018
    • Factor Seventeen 2017 Tax Reform Legislation Consequences
    • Factor Eighteen: Physician Shortage, NP Surplus
      • Physician Shortage
      • Advanced Practice Nurse Surplus
      • Older Workers
    • Factor Nineteen: Urgent Care and Retail Clinics
      • Urgent Care Centers
      • Retail Clinics
      • Other Healthcare Venues
    • Factor Twenty: U.S. Opioid Crisis
    • Factor Twenty-One: Ransomware and Cybercrime
  • Key Issues: Europe
    • Introduction
      • Table Key Indicators: Western Europe, Eastern Europe, Switzerland, Russia, 2017
      • Economic Rebound in the Eurozone
    • Factor Twenty-Two: Brexit
    • Factor Twenty-Three: Austerity
      • UK
    • Factor Twenty-Four: Bailout EU Nations: Greece, Ireland, Portugal, Spain, Cypress
      • Technology Laggership in Europe
      • High Costs of Doing Business
  • Key Issues: Emerging Markets
    • Introduction
      • Table Characteristics of Tier I, II and III Players, 2017
    • Factor Twenty Five: Developed Nations Turn to Biotech
      • Table Key Indicators: Tier I Countries, 2017
      • Growing Pharma and Biotech Industries
    • Factor Twenty-Six: Rise of Eastern Europe
      • China and India
        • Table Key Indicators: Tier II Countries, 2017
      • Changing Disease Patterns
    • Factor Twenty-Seven: China/India Healthcare Reform, Brazil Pharma Reform
      • Table Key Healthcare Reforms and Remaining Current Gaps in China and India, 1997 - 2017
      • Intellectual Property Struggles
      • Corporate Incentives
      • China and India Focus on Biotech
      • Shift from Generics to Innovative Products
      • Outsourcing Boom
      • Tier III Countries
      • Brazil Pharma's Boom
      • Political and Economic Instability
  • Considering the 27 Factors - Best/Worst/Moderate Case Market Forecasts
    • Overview
    • Total Healthcare Market Forecasts
      • Table Total Global Healthcare Market in $ Billions, Historic, Best Case, Most Likely & Worst Case, 2007 - 2027, in $Billions
      • Table Total Global Healthcare Market Growth for Best Case, Most Likely & Worst Case, 2017 - 2027, in $Billions
      • U.S. Healthcare Market
        • Table Total U.S. Healthcare Market, Best Case, Most Likely & Worst Case, 2007 - 2027 ($BN)
        • Table Total Global Healthcare Market Growth for Best Case, Most Likely & Worst Case, 2017 - 2027, in $Billions
      • Europe Healthcare Market
        • Table Total European Healthcare Market: Best Case, Most Likely & Worst Case, 2007 - 2027 ($BN)
        • Table Total European Healthcare Market Growth for Best Case, Most Likely & Worst Case, 2017 - 2027, in $Billions
      • Asia Healthcare Market
        • Table Total Asian Healthcare Market: Best Case, Most Likely & Worst Case, 2007 - 2027($BN)
        • Table Total Asian Healthcare Market Growth for Best Case, Most Likely & Worst Case, 2017 2027, in $Billions
    • Total Pharmaceutical Market Forecasts
      • Table Total Global Pharmaceutical Market: Best Case, Most Likely & Worst Case, 2007 - 2027 ($BN)
      • Table Total Global Pharmaceutical Market: Best Case, Most Likely & Worst Case, 2017 - 2027, in $Billions
      • U.S. Pharmaceutical Market
        • Table U.S. Pharmaceutical Market: Best Case, Most Likely & Worst Case, 2007 - 2027 ($BN)
        • Table Total U.S. Biopharmaceutical Market Growth for Best Case, Most Likely & Worst Case, 2017 - 2027, in $Billions
      • Europe Pharmaceutical Market
        • Table European Pharmaceutical Market: Best Case, Most Likely & Worst Case, 2007 - 2027 ($BN)
        • Table Total European Pharmaceutical Market Growth for Best Case, Most Likely & Worst Case, 2017 - 2027, in $Billions
      • Asia Pharmaceutical Market
        • Table Asian Pharmaceutical Market: Best Case, Most Likely & Worst Case, 2007 - 2027 ($BN)
        • Table Total Asian Pharmaceutical Market Growth for Best Case, Most Likely & Worst Case, 2017 - 2027, in $Billions